Correction: A two-tier protection strategy for oral delivery of GLP-1 peptides: lipid-based formulation combined with enteric capsules
- Camille Dumont1
- Vanessa Gonzalez1
- Paula Klatt1
- Sandrine Picco1
- Delphine Nombret1
- Marine Agisson1
- Euengla Uku1
- Thibault Saurel1
- Vincent Jannin1*corresponding author
- Capsugel France SAS, Colmar, France
Abstract
Keywords
In the abstract, line 12, there is an inversion on the log P values of the EXE-HIP and EXE, it currently reads “(log P = −2.9 ± 0.3 vs. 0.9 ± 0.2 for EXE)”. This has been corrected to read: “(log P = 0.9 ± 0.2 vs. −2.9 ± 0.3 for EXE)”.
The original version of this article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Footnotes
Edited and reviewed by: Javier O. Morales, University of Chile, Chile
Citation
Dumont, C., et al. (2026). Correction: A two-tier protection strategy for oral delivery of GLP-1 peptides: lipid-based formulation combined with enteric capsules. Frontiers in Drug Delivery, Volume 6. https://doi.org/
- Received
- Accepted
- Published
- Volume
- 6 - 2026
Copyright
Copyright © 2026 Dumont, Gonzalez, Klatt, Picco, Nombret, Agisson, Uku, Saurel and Jannin.
License: https://creativecommons.org/licenses/by/4.0/
*Correspondence: Vincent Jannin
Article metrics
- Views
- 0
- Downloads
- 0
- Citations
- 0
- Shares
- 0
